Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Income towards Parent Company (2020 - 2025)

Historic Income towards Parent Company for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to -$29.4 million.

  • Caribou Biosciences' Income towards Parent Company rose 2311.31% to -$29.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$158.8 million, marking a year-over-year increase of 388.48%. This contributed to the annual value of -$149.1 million for FY2024, which is 4608.11% down from last year.
  • Per Caribou Biosciences' latest filing, its Income towards Parent Company stood at -$29.4 million for Q3 2025, which was up 2311.31% from -$47.6 million recorded in Q2 2025.
  • Over the past 5 years, Caribou Biosciences' Income towards Parent Company peaked at -$13.2 million during Q1 2021, and registered a low of -$47.6 million during Q2 2025.
  • In the last 5 years, Caribou Biosciences' Income towards Parent Company had a median value of -$30.6 million in 2022 and averaged -$30.3 million.
  • In the last 5 years, Caribou Biosciences' Income towards Parent Company crashed by 66447.65% in 2021 and then surged by 4485.81% in 2023.
  • Quarter analysis of 5 years shows Caribou Biosciences' Income towards Parent Company stood at -$18.5 million in 2021, then plummeted by 65.47% to -$30.6 million in 2022, then fell by 22.45% to -$37.4 million in 2023, then dropped by 3.83% to -$38.9 million in 2024, then increased by 24.37% to -$29.4 million in 2025.
  • Its Income towards Parent Company was -$29.4 million in Q3 2025, compared to -$47.6 million in Q2 2025 and -$42.9 million in Q1 2025.